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cance for reduction in antibiotic ﬁlls. The provider survey
showed statistically signiﬁcant self-reported differences between
the intervention and control clinic providers in the hypothesized
direction for all three outcome measures. Signiﬁcant differences
in outcomes were seen by provider type (family practice, urgent
care, or pediatrician). CONCLUSIONS: Analyses of claims data
showed a reduction in the diagnosis of AOM and increased ﬁlls
of analgesic drops for pain, as hypothesized. Improvement was
more marked in the self-reports than in the claims data. Outcome
differences were mediated by provider specialty.
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OBJECTIVES: Numerous studies have evaluated the impact of
various guideline implementation interventions and have 
found different results for seemingly similar interventions. To
investigate this issue, we conducted a process evaluation of a
multi-faceted otitis media guideline intervention that examined
intervention details, degree of provider exposure, and provider
perceptions. METHODS: Ten primary care clinics in a south-
western integrated delivery system were organized into matched
pairs and assigned to control status (mailed guidelines only) or
intervention status (provider exposure to formal education,
guideline tools, reinforcement messages, and feedback).
Researchers documented the nature and timing of the multiple
interventions, degree of intervention exposure (training atten-
dance by intervention clinic providers, provider self-report of
intervention exposure), and experience of providers (provider
ranking of each intervention’s value). RESULTS: Training atten-
dance varied signiﬁcantly across intervention clinics and by spe-
cialty, with family practitioners having higher attendance (64%)
than urgent care providers (57%) or pediatricians (47%).
Providers attending the formal training were more guideline-
compliant pre-intervention than those who did not attend. Of
the ten interventions, two-thirds or more of the providers
recalled having seen or participated in: the guidelines, the formal
training, the repair of otoscopes, the laminated guideline
summary card, and the ofﬁce poster. The interventions ranked
as highest in value were: repair of the otoscopes, the formal train-
ing, and the guidelines. CONCLUSIONS: The different pre-
intervention practice patterns found for providers who attended
the training vs. those who did not suggests the importance of
adjusting for this factor in analyzing intervention impact on
guideline compliance. The most concrete and basic interven-
tion—repair of the otoscopes—was best remembered and most
valued by the providers, perhaps because it is central to the accu-
rate diagnosis of otitis. The latter further suggests the importance
of a needs assessment to tailor the speciﬁc interventions to the
particular practice setting.
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OBJECTIVES: To investigate comorbidities associated with
glaucoma and trend of glaucoma incidence in the California
Medicaid population. METHODS: A retrospective case-control
study was conducted using 20% sample of the Medi-Cal admin-
istrative claims data from January 1, 1995 to December 31,
2002. Patients with glaucoma were identiﬁed using ICD-9 diag-
nosis (ICD-9 = 365.xx) and were 1 :3 randomly matched to a
cohort without glaucoma based on age and gender. Eligibility
was measured by the number of enrollment months. Relative risk
(RR) was calculated to estimate the risk of glaucoma patients to
a proﬁle of 25 comorbidities set forth by AHRQ. RESULTS: A
total of 32,395 glaucoma patients were matched to 97,185 con-
trols. The mean age was 65.5 (+/-19.8) and 34.9% were male.
Over the eight years of study period, glaucoma patients had 
signiﬁcantly longer length of Medi-Cal eligibility than non-
glaucoma patients (71.6 vs. 50.8 months, p < 0.0001). African
Americans were at signiﬁcantly higher risk of glaucoma (RR =
1.53) and Hispanics had lower risk (RR = 0.74). Patients with
glaucoma were at signiﬁcantly higher risk for most diseases, such
as rheumatoid arthritis (RR = 1.49), hypothyroidism (RR =
1.39), diabetes (RR = 1.35), valvular diseases (RR = 1.35),
depression (RR = 1.32) and peripheral vascular diseases (RR =
1.26). The yearly incidence rate for glaucoma decreased over
time from 48.5 per 10,000 person-year in 1995 to 18.6 per
10,000 person-year in 2002. The average incidence rate for 
glaucoma patients was 29.0 per 10,000 person-year during 
the eight-year study duration. CONCLUSIONS: The glaucoma 
population suffers from numerous comorbidities, although it is
not clear whether they affect treatment alternatives. The inci-
dence rate of glaucoma sharply declined from 1995 to 2002 in
Medi-Cal population.
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OBJECTIVES: The objective of this study was to determine the
frequency and describe the reasons for changes in pharma-
cotherapy in the treatment of primary open-angle glaucoma
(POAG), normal tension glaucoma (NTG), and ocular hyper-
tension (OH). METHODS: Retrospective analysis was con-
ducted of the Glasgow Royal Inﬁrmary Glaucoma Database. The
database was comprised of computerized medical records of all
POAG, NTG, and OH patients treated at the Glasgow Royal
Inﬁrmary from 1981 to present, representing 745 patients or
>5000 treatment years. Data elements recorded for each patient
included demographics, diagnosis, and treatment history. Treat-
ment history included initial and subsequent medication regi-
mens. Changes in medication regimens were categorized by
failure to reach or maintain target pressure, adverse effects, disc
and visual ﬁeld progression, compliance, surgery or surgical
failure, and other reasons. Descriptive statistics were used to
analyze patient demographics and distributions by study vari-
ables. RESULTS: Among the 745 patients, there were 2049
changes in treatment during the study period. Frequency of treat-
ment changes were failure to reach target pressure (29%), failure
to maintain target pressure (17%), adverse effects (20%),
surgery (11%), failure of surgery (5%), disc progression (5%),
visual ﬁeld progression (5%), compliance (3%), and other
